Invention Grant
US08980913B2 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
有权
具有毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂活性的化合物
- Patent Title: Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
- Patent Title (中): 具有毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂活性的化合物
-
Application No.: US14098662Application Date: 2013-12-06
-
Publication No.: US08980913B2Publication Date: 2015-03-17
- Inventor: Fabio Rancati , Ian Linney , Chris Knight , Wolfgang Schmidt
- Applicant: Chiesi Farmaceutici S.p.A.
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP12195898 20121206
- Main IPC: A61K31/04
- IPC: A61K31/04 ; C07D215/38 ; A61K31/4709 ; A61K45/06 ; A61M15/00 ; A61M16/14 ; C07D453/02
Abstract:
Compounds of formula (I) defined herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.
Public/Granted literature
- US20140163066A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Public/Granted day:2014-06-12
Information query
